This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Michael E Leventon: Innovator in Ophthalmic Augmented Reality
Introduction
Michael E Leventon is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of ophthalmology through his innovative work in augmented reality technology. His expertise and dedication have led to the development of a unique patent that enhances the precision of laser treatments for ophthalmic diseases.
Latest Patents
Michael E Leventon holds a patent for a "Technique for creating an ophthalmic augmented reality environment." This invention aims to facilitate more precise laser treatment for ophthalmic diseases, as well as applications in teaching, telemedicine, and real-time image measurement, analysis, and comparison. The system is designed around a standard slit-lamp biomicroscope, which is interfaced with a CCD camera. The captured images are processed and displayed in a way that allows for enhanced visualization and analysis.
Career Highlights
Leventon is affiliated with the University of Pennsylvania, where he continues to work on advancing technologies in the medical field. His innovative approach has garnered attention and respect within the ophthalmic community. With a focus on improving patient outcomes, his work exemplifies the intersection of technology and healthcare.
Collaborations
Michael E Leventon has collaborated with esteemed colleagues such as Jeffrey W Berger and Ron Kikinis. These partnerships have further enriched his research and development efforts, leading to advancements in ophthalmic technologies.
Conclusion
Michael E Leventon's contributions to ophthalmic augmented reality represent a significant advancement in medical technology. His innovative patent and collaborative efforts continue to pave the way for improved treatments in ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
